← Leaderboards
Shiwen Peng
Johns Hopkins University
$489,630
Attributed
$489,630
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $97.9K · FY2020–24$100K$75K$50K$25K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$489,630 · 1
By mechanism
R50$489,630 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Richard Bruce Roden$11,133,737
- Cornelia L Trimble$7,319,162
- Chien-Fu Hung$6,457,345
- Elizabeth Marion Jaffee$29,780,612
- Joseph A Califano$16,242,638
Others in their field
Other Emerging Leaders on “Immunotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,653,178
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,640,671
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,755,085
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,983,611
Research focus
ImmunotherapyImmunology ProcedureImmunotherapeutic AgentCancer ImmunotherapyApplications GrantsClinical CareClinical InvestigatorCancer BiologyClinical TrialsCollaborationsCancer PatientDesignDna VaccinesExperimental StudyFoundationsGene GunGenerationsClinical TranslationHuman PapillomavirusHuman Papillomavirus 16Human Papilloma Virus-Related Malignant NeoplasmImmunologicsImmunologyInnovation
Grant awards (5)
Development and Characterization of Immunotherapies for HPV-Associated Malignancies$97,926
R50 · FY2024 · CA · contact PI
Development and Characterization of Immunotherapies for HPV-Associated Malignancies$97,926
R50 · FY2023 · CA · contact PI
Development and Characterization of Immunotherapies for HPV-Associated Malignancies$97,926
R50 · FY2022 · CA · contact PI
Development and Characterization of Immunotherapies for HPV-Associated Malignancies$97,926
R50 · FY2021 · CA · contact PI
Development and Characterization of Immunotherapies for HPV-Associated Malignancies$97,926
R50 · FY2020 · CA · contact PI